At the same time, inhibitors of butyrylcholinesterase enzyme, which hydrolyzes acetylcholine in AD, are thoroughly being studied as indispensable parts of therapeutic strategies in AD (Li et al., 2017[16]). Here, BCHE is linked to Alzheimer disease.